ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,660 | +65.1% | 25,932 | +216.2% | 0.00% | 0.0% |
| Q2 2023 | $175,480 | -63.7% | 8,200 | -31.5% | 0.00% | 0.0% |
| Q1 2023 | $483,986 | -64.3% | 11,968 | -58.3% | 0.00% | -83.3% |
| Q2 2022 | $1,357,000 | +3891.2% | 28,700 | +7075.0% | 0.01% | – |
| Q2 2019 | $34,000 | -95.3% | 400 | -95.2% | 0.00% | -100.0% |
| Q3 2018 | $718,000 | -58.5% | 8,400 | -85.1% | 0.00% | -70.0% |
| Q1 2017 | $1,731,000 | – | 56,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |